Product information

Edronax 4 mg
60
reboxetine
1374032
9.08 / 10
Locked

Product properties

71620-89-8
N06AX18
Pfizer
Tablet, Tablet
€20.39
BE190251
05415062305546
M1
Public
190251-04

Pharmacist Assessment

Normally available

This product has good current availability (score 9.08/10) and is historically stable (score 🔒/10). No action required.

Note: commercialization of this product will be stopped on 31/08/2026.

Equivalent products

Tier A: Direct equivalents

Tier B: Galenic alternatives

Tier C: Strength alternatives

Tier D: ATC equivalents (parallel import)

Tier E: Active substances (magistral)

Stock overview

Availability in Freemium
  • 17 of 18 warehouse locations have stock
  • 3 of the 3 wholesalers have stock

Detailed stock insights are available for registered users

Create a free Curadar Freemium account to view detailed stock data from Febelco, Phoenix and CERP.

Available alternatives

Status history (PharmaStatus)

Commercialization stopped Planned
From 31/08/2026

Commercial reasons

Alternative available
Available Active
Until 30/08/2026

Composition

1 ingredient

Substance Type Strength CAS
Active ingredient
5.22 mg

Additional information

Availability statistics

Available
0 days
2
0